ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 999

Identification of New Epistatic Interactions with the HLA Region in the Genetic Etiology of Psoriasis and Psoriatic Arthritis

Sara Marsal1, Juan D. Cañete2, Jose Luis Fernandez-Sueiro3, Raimon Sanmarti2, Jesus Rodriguez Moreno4, Jordi Gratacós5, Rubén Queiro6, Carlos Montilla7, Juan Carlos Torre-Alonso8, Jose Perez Venegas9, Santiago Muñoz-Fernández10, Carlos M. Gonzalez11, Daniel Roig12, Alba Erra13, Isabel Acosta1, Antonio Fernández-Nebro14, Pedro Zarco15, Arnald Alonso16, María América López-Lasanta16, Raül Tortosa16 and Antonio Julià16, 1Rheumatology Service, Hospital Universitari Vall d'Hebron, Barcelona, Spain, 2Rheumatology Service, Hospital Clínic of Barcelona, Barcelona, Spain, 3Rheumatology Service, Complejo Hospitalario Universitario La Coruña, La Coruña, Spain, 4Rheumatology Service, Hospital Universitario de Bellvitge., Barcelona, Spain, 5Rheumatology Service, Hospital Universitari Parc Taulí, Sabadell (Barcelona), Spain, 6Rheumatology Service, Hospital Universitario Central de Asturias, Oviedo, Spain, 7Rheumatology Service, Hospital Universitario de Salamanca, Salamanca, Spain, 8H. Monte Naranco, Oviedo, Spain, 9Rheumatology Service, Hospital del SAS de Jerez de la Frontera, Jerez De La Frontera, Spain, 10Unit Rheumatology, Hospital Universitario Infanta Sofía, San Sebastián de los Reyes (Madrid), Spain, 11Rheumatology, Hospital Gregorio Maranon, Madrid, Spain, 12Rheumatology Service, Hospital Universitari de Bellvitge, Hospitalet de Llobregat- Barcelona, Spain, 13Rheumatology Service, Hospital San Rafael, Barcelona, Spain, 14Rheumatology Service, Hospital Regional Universitario Carlos Haya, Málaga, Spain, 15Rheumatology Service, Fundación Hospital Alcorcon, Alcorcon, Madrid, Spain, 16Rheumatology Research Group, Vall d'Hebron Hospital Research Institute, Barcelona, Spain

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: genomics, psoriatic arthritis and risk assessment

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Genetics and Genomics of Rheumatic Diseases

Session Type: Abstract Submissions (ACR)

Background/Purpose: Psoriatic Arthritis (PsA) is a complex disease and is present in ~11% in patients with Psoriasis (Ps). Recently, Genomewide Association Studies (GWAS) have expanded the number of risk loci for Ps in >20 new loci. Two of these genes, ERAP-1 and HLA-C, have been shown to interact epistatically in the risk to develop Ps. We have studied the presence of new genetic interactions between Ps risk lci with the HLA region in Purely cutaneous Psoriasis (PsC) and PsA.

Methods: Within each Ps risk locus (n=31), the SNP having the highest statistical evidence was selected. The 31 SNPs were genotyped using Taqman technology in a cohort of n = 955 PsA, 1,050 PsC and 1,497 hypernormal controls of the Spanish population. The presence of statistically significant gene-gene interactions was performed using a logistic regression model with three parameters to determine the presence of interaction at the allelic level.

Results: : We replicated the previously described interaction of HLA-C and ERAP1 in the PsC cohort but not in the PsA cohort. We identified, for the first time, a significative epistatic association between HLA-C and SERPINB8. Microarray gene expression studies on cutaneous biopsies corroborate the presence of this interaction at a functional level. In PsA, no statistically significant interactions where identified with variation at HLA-C. However, 6 of the studied genes showed a significant (P<0.05) association with HLA-B27 positivity.

Conclusion: The present study has identified new genetic interactions associated with the risk to develop PsC and PsA. The functional study of these interactions will improve our knowledge of the biological basis of these complex diseases.


Disclosure:

S. Marsal,
None;

J. D. Cañete,
None;

J. L. Fernandez-Sueiro,
None;

R. Sanmarti,
None;

J. Rodriguez Moreno,
None;

J. Gratacós,
None;

R. Queiro,
None;

C. Montilla,
None;

J. C. Torre-Alonso,
None;

J. Perez Venegas,
None;

S. Muñoz-Fernández,
None;

C. M. Gonzalez,
None;

D. Roig,
None;

A. Erra,
None;

I. Acosta,
None;

A. Fernández-Nebro,
None;

P. Zarco,
None;

A. Alonso,
None;

M. A. López-Lasanta,
None;

R. Tortosa,
None;

A. Julià,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/identification-of-new-epistatic-interactions-with-the-hla-region-in-the-genetic-etiology-of-psoriasis-and-psoriatic-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology